BHC
Bausch Health Companies Inc.$5.71+0.13 (+2.33%)Prev Close$5.58·MCap$2.14B·P/E13.67·Vol2.16M·Yield—
▲
Buys (12M)
4
$369.63M
▼
Sells (12M)
3
$742.9K
◆
Net Activity
Net Buyer
$368.89M
●
Active Insiders
4
last 12 mo
Over the past 12 months, insider activity at Bausch Health Companies Inc. (BHC) has been dominated by buying, with 4 insider purchases totaling $369.63M and 3 insider sales totaling $742.9K. The most recent insider transaction was by Carson Seana (EVP, General Counsel), who sold $475.1K worth of shares on Sep 5, 2025. Bausch Health Companies Inc. operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry, with a market cap of $2.14B.
BHC Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 5, 2025 | Carson Seana | EVP, General Counsel | Sell | 64,707 | $7.34 | $475.1K | 0 |
| Aug 21, 2025 | Lee Frank D. | Director | Sell | 15,912 | $7.66 | $121.9K | 0 |
| Aug 14, 2025 | Paulson John | Director | Buy | 34,721,118 | $9.00 | $312.49M9.4% OS | 0 |
| Aug 11, 2025 | Paulson John | Director | Buy | 3,243,049 | $6.56 | $21.27M0.9% OS | 0 |
| Jul 15, 2025 | Lenar Aimee J. | EVP, US Pharma | Sell | 22,736 | $6.42 | $146.0K | 0 |
| Jun 13, 2025 | Paulson John | Director | Buy | 3,564,059 | $5.94 | $21.17M1.0% OS | 0 |
| Jun 10, 2025 | Paulson John | Director | Buy | 2,788,608 | $5.27 | $14.70M0.8% OS | 0 |
| Feb 28, 2025 | APPIO THOMAS | Chief Executive Officer | Sell | 206,849 | $7.44 | $1.54M | 0 |
| Feb 28, 2025 | Barresi John S | SVP, Controller & CAO | Sell | 7,961 | $7.44 | $59.2K | 0 |
| Feb 28, 2025 | Carson Seana | EVP, General Counsel | Sell | 49,292 | $7.44 | $366.7K | 0 |
| Nov 29, 2024 | Carson Seana | EVP, General Counsel | Sell | 2,132 | $8.37 | $17.8K | 0 |
| Sep 5, 2024 | Barresi John S | SVP, Controller & CAO | Sell | 3,982 | $6.19 | $24.6K | 0 |
| Sep 5, 2024 | Carson Seana | EVP, General Counsel | Sell | 64,707 | $6.19 | $400.8K | 0 |
| Aug 30, 2024 | APPIO THOMAS | Chief Executive Officer | Sell | 14,683 | $5.93 | $87.1K | 0 |
| Jun 20, 2024 | Barresi John S | SVP, Controller & CAO | Sell | 1,930 | $6.73 | $13.0K | 0 |
| Feb 29, 2024 | APPIO THOMAS | Chief Executive Officer | Sell | 116,982 | $9.89 | $1.16M | 0 |
| Feb 29, 2024 | Barresi John S | SVP, Controller & CAO | Sell | 3,188 | $9.89 | $31.5K | 0 |
| Feb 29, 2024 | Carson Seana | EVP, General Counsel | Sell | 30,556 | $9.87 | $301.6K | 0 |
| Dec 1, 2023 | Carson Seana | EVP, General Counsel | Sell | 1,911 | $7.36 | $14.1K | 0 |
| Nov 3, 2023 | Carson Seana | EVP, General Counsel | Sell | 377 | $7.57 | $2.9K | 0 |
| Sep 5, 2023 | Barresi John S | SVP, Controller & CAO | Sell | 3,982 | $8.35 | $33.2K | 0 |
| Sep 5, 2023 | Carson Seana | EVP, General Counsel | Sell | 58,022 | $8.34 | $484.0K | 0 |
| Sep 5, 2023 | Vadaketh Tom George | EVP, Chief Financial Officer | Sell | 43,948 | $8.35 | $367.0K | 0 |
| Sep 1, 2023 | APPIO THOMAS | Chief Executive Officer | Sell | 14,111 | $8.46 | $119.4K | 0 |
| Jun 20, 2023 | Barresi John S | SVP, Controller & CAO | Sell | 1,929 | $7.40 | $14.3K | 0 |
| Mar 2, 2023 | APPIO THOMAS | Chief Executive Officer | Sell | 27,607 | $9.22 | $254.4K | 0 |
| Mar 2, 2023 | Carson Seana | EVP, General Counsel | Sell | 11,069 | $9.22 | $102.1K | 0 |
| Mar 2, 2023 | Vadaketh Tom George | EVP, Chief Financial Officer | Sell | 4,001 | $9.25 | $37.0K | 0 |
| Feb 27, 2023 | APPIO THOMAS | Chief Executive Officer | Sell | 6,327 | $9.57 | $60.5K | 0 |
| Feb 27, 2023 | Carson Seana | EVP, General Counsel | Sell | 2,534 | $9.54 | $24.2K | 0 |
| Jan 3, 2023 | Vadaketh Tom George | EVP, Chief Financial Officer | Sell | 6,310 | $6.28 | $39.6K | 0 |
| Dec 1, 2022 | Carson Seana | EVP, General Counsel | Sell | 1,691 | $7.70 | $13.0K | 0 |
| Nov 3, 2022 | Carson Seana | EVP, General Counsel | Sell | 334 | $6.45 | $2.2K | 0 |
| Sep 1, 2022 | APPIO THOMAS | Chief Executive Officer | Sell | 15,389 | $6.59 | $101.4K | 0 |
| May 10, 2022 | PAPA JOSEPH C | Director | Sell | 33,714 | $9.40 | $316.9K | 0 |
| May 3, 2022 | Munsch Frederick | SVP, Controller and CAO | Sell | 747 | $18.66 | $13.9K | 0 |
| Apr 14, 2022 | Spurr Robert | U.S. President-Pharma Business | Sell | 1,595 | $22.19 | $35.4K | 0 |
| Mar 15, 2022 | Spurr Robert | U.S. President-Pharma Business | Sell | 4,846 | $22.20 | $107.6K | 0 |
| Mar 10, 2022 | ACKERMANN CHRISTINA | EVP AND GENERAL COUNSEL | Sell | 839 | $22.56 | $18.9K | 0 |
| Mar 8, 2022 | Gordon Joseph F | Pres&Co-Head Bausch&Lomb/Int'l | Sell | 3,889 | $21.76 | $84.6K | 0 |
| Mar 3, 2022 | ACKERMANN CHRISTINA | EVP AND GENERAL COUNSEL | Sell | 6,926 | $23.61 | $163.5K | 0 |
| Mar 3, 2022 | APPIO THOMAS | CEO, Pharma Business | Sell | 5,564 | $23.61 | $131.4K | 0 |
| Mar 3, 2022 | Eldessouky Sam | EVP & Chief Financial Officer | Sell | 1,242 | $23.61 | $29.3K | 0 |
| Mar 3, 2022 | Munsch Frederick | SVP, Controller and CAO | Sell | 608 | $23.61 | $14.4K | 0 |
| Mar 3, 2022 | PAPA JOSEPH C | CHAIRMAN & CEO | Sell | 12,643 | $23.61 | $298.5K | 0 |
| Mar 3, 2022 | Spurr Robert | U.S. President-Pharma Business | Sell | 4,074 | $23.61 | $96.2K | 0 |
| Mar 2, 2022 | Gordon Joseph F | Pres&Co-Head Bausch&Lomb/Int'l | Sell | 11,077 | $23.37 | $258.9K | 0 |
| Mar 2, 2022 | Spurr Robert | U.S. President-Pharma Business | Sell | 1,595 | $23.37 | $37.3K | 0 |
| Feb 26, 2022 | ACKERMANN CHRISTINA | EVP AND GENERAL COUNSEL | Sell | 16,028 | $24.35 | $390.3K | 0 |
| Feb 26, 2022 | APPIO THOMAS | CEO, Pharma Business | Sell | 13,376 | $24.35 | $325.7K | 0 |
Showing 1–50 of 82
1 / 2
BHC Insider Buying Activity
The following table shows recent insider purchases of Bausch Health Companies Inc. (BHC) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 14, 2025 | Paulson John | Director | Buy | 34,721,118 | $9.00 | $312.49M9.4% OS | 0 |
| Aug 11, 2025 | Paulson John | Director | Buy | 3,243,049 | $6.56 | $21.27M0.9% OS | 0 |
| Jun 13, 2025 | Paulson John | Director | Buy | 3,564,059 | $5.94 | $21.17M1.0% OS | 0 |
| Jun 10, 2025 | Paulson John | Director | Buy | 2,788,608 | $5.27 | $14.70M0.8% OS | 0 |
BHC Insider Selling Activity
The following table shows recent insider sales of Bausch Health Companies Inc. (BHC) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 5, 2025 | Carson Seana | EVP, General Counsel | Sell | 64,707 | $7.34 | $475.1K | 0 |
| Aug 21, 2025 | Lee Frank D. | Director | Sell | 15,912 | $7.66 | $121.9K | 0 |
| Jul 15, 2025 | Lenar Aimee J. | EVP, US Pharma | Sell | 22,736 | $6.42 | $146.0K | 0 |
| Feb 28, 2025 | APPIO THOMAS | Chief Executive Officer | Sell | 206,849 | $7.44 | $1.54M | 0 |
| Feb 28, 2025 | Barresi John S | SVP, Controller & CAO | Sell | 7,961 | $7.44 | $59.2K | 0 |
| Feb 28, 2025 | Carson Seana | EVP, General Counsel | Sell | 49,292 | $7.44 | $366.7K | 0 |
| Nov 29, 2024 | Carson Seana | EVP, General Counsel | Sell | 2,132 | $8.37 | $17.8K | 0 |
| Sep 5, 2024 | Barresi John S | SVP, Controller & CAO | Sell | 3,982 | $6.19 | $24.6K | 0 |
| Sep 5, 2024 | Carson Seana | EVP, General Counsel | Sell | 64,707 | $6.19 | $400.8K | 0 |
| Aug 30, 2024 | APPIO THOMAS | Chief Executive Officer | Sell | 14,683 | $5.93 | $87.1K | 0 |
| Jun 20, 2024 | Barresi John S | SVP, Controller & CAO | Sell | 1,930 | $6.73 | $13.0K | 0 |
| Feb 29, 2024 | APPIO THOMAS | Chief Executive Officer | Sell | 116,982 | $9.89 | $1.16M | 0 |
| Feb 29, 2024 | Barresi John S | SVP, Controller & CAO | Sell | 3,188 | $9.89 | $31.5K | 0 |
| Feb 29, 2024 | Carson Seana | EVP, General Counsel | Sell | 30,556 | $9.87 | $301.6K | 0 |
| Dec 1, 2023 | Carson Seana | EVP, General Counsel | Sell | 1,911 | $7.36 | $14.1K | 0 |
| Nov 3, 2023 | Carson Seana | EVP, General Counsel | Sell | 377 | $7.57 | $2.9K | 0 |
| Sep 5, 2023 | Barresi John S | SVP, Controller & CAO | Sell | 3,982 | $8.35 | $33.2K | 0 |
| Sep 5, 2023 | Carson Seana | EVP, General Counsel | Sell | 58,022 | $8.34 | $484.0K | 0 |
| Sep 5, 2023 | Vadaketh Tom George | EVP, Chief Financial Officer | Sell | 43,948 | $8.35 | $367.0K | 0 |
| Sep 1, 2023 | APPIO THOMAS | Chief Executive Officer | Sell | 14,111 | $8.46 | $119.4K | 0 |
| Jun 20, 2023 | Barresi John S | SVP, Controller & CAO | Sell | 1,929 | $7.40 | $14.3K | 0 |
| Mar 2, 2023 | APPIO THOMAS | Chief Executive Officer | Sell | 27,607 | $9.22 | $254.4K | 0 |
| Mar 2, 2023 | Carson Seana | EVP, General Counsel | Sell | 11,069 | $9.22 | $102.1K | 0 |
| Mar 2, 2023 | Vadaketh Tom George | EVP, Chief Financial Officer | Sell | 4,001 | $9.25 | $37.0K | 0 |
| Feb 27, 2023 | APPIO THOMAS | Chief Executive Officer | Sell | 6,327 | $9.57 | $60.5K | 0 |
| Feb 27, 2023 | Carson Seana | EVP, General Counsel | Sell | 2,534 | $9.54 | $24.2K | 0 |
| Jan 3, 2023 | Vadaketh Tom George | EVP, Chief Financial Officer | Sell | 6,310 | $6.28 | $39.6K | 0 |
| Dec 1, 2022 | Carson Seana | EVP, General Counsel | Sell | 1,691 | $7.70 | $13.0K | 0 |
| Nov 3, 2022 | Carson Seana | EVP, General Counsel | Sell | 334 | $6.45 | $2.2K | 0 |
| Sep 1, 2022 | APPIO THOMAS | Chief Executive Officer | Sell | 15,389 | $6.59 | $101.4K | 0 |
| May 10, 2022 | PAPA JOSEPH C | Director | Sell | 33,714 | $9.40 | $316.9K | 0 |
| May 3, 2022 | Munsch Frederick | SVP, Controller and CAO | Sell | 747 | $18.66 | $13.9K | 0 |
| Apr 14, 2022 | Spurr Robert | U.S. President-Pharma Business | Sell | 1,595 | $22.19 | $35.4K | 0 |
| Mar 15, 2022 | Spurr Robert | U.S. President-Pharma Business | Sell | 4,846 | $22.20 | $107.6K | 0 |
| Mar 10, 2022 | ACKERMANN CHRISTINA | EVP AND GENERAL COUNSEL | Sell | 839 | $22.56 | $18.9K | 0 |
| Mar 8, 2022 | Gordon Joseph F | Pres&Co-Head Bausch&Lomb/Int'l | Sell | 3,889 | $21.76 | $84.6K | 0 |
| Mar 3, 2022 | ACKERMANN CHRISTINA | EVP AND GENERAL COUNSEL | Sell | 6,926 | $23.61 | $163.5K | 0 |
| Mar 3, 2022 | APPIO THOMAS | CEO, Pharma Business | Sell | 5,564 | $23.61 | $131.4K | 0 |
| Mar 3, 2022 | Eldessouky Sam | EVP & Chief Financial Officer | Sell | 1,242 | $23.61 | $29.3K | 0 |
| Mar 3, 2022 | Munsch Frederick | SVP, Controller and CAO | Sell | 608 | $23.61 | $14.4K | 0 |
| Mar 3, 2022 | PAPA JOSEPH C | CHAIRMAN & CEO | Sell | 12,643 | $23.61 | $298.5K | 0 |
| Mar 3, 2022 | Spurr Robert | U.S. President-Pharma Business | Sell | 4,074 | $23.61 | $96.2K | 0 |
| Mar 2, 2022 | Gordon Joseph F | Pres&Co-Head Bausch&Lomb/Int'l | Sell | 11,077 | $23.37 | $258.9K | 0 |
| Mar 2, 2022 | Spurr Robert | U.S. President-Pharma Business | Sell | 1,595 | $23.37 | $37.3K | 0 |
| Feb 26, 2022 | ACKERMANN CHRISTINA | EVP AND GENERAL COUNSEL | Sell | 16,028 | $24.35 | $390.3K | 0 |
| Feb 26, 2022 | APPIO THOMAS | CEO, Pharma Business | Sell | 13,376 | $24.35 | $325.7K | 0 |
BHC Insiders
Similar Stocks to BHC
ZTS
Zoetis Inc.
$116.49-1.17%
$51.80B
VTRS
Viatris Inc.
$14.76-0.27%
$17.15B
NBIX
Neurocrine Biosciences, Inc.
$128.16+0.10%
$13.07B
INDV
Indivior Pharmaceuticals Inc
$34.23-0.23%
$4.15B
SUPN
Supernus Pharmaceuticals, Inc.
$48.70-1.54%
$2.87B
PAHC
Phibro Animal Health Corporation
$53.65-4.44%
$2.19B
ANIP
ANI Pharmaceuticals, Inc.
$78.91-0.87%
$1.79B
PRGO
Perrigo Company plc
$11.53+0.30%
$1.61B